Bryan R. Lawrence - Oakcliff Capital Partners 13F Activity & Position Changes (Q4 2021)
According to the SEC 13F filed on Feb 14, 2022, the Oakcliff Capital Partners portfolio showed several notable changes in holdings as of quarter-end Dec 31, 2021. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q4 2021, the filing reported:
New Buys - GoodRx Holdings, Inc.
Increases - Cardlytics, Inc. Common Stock, Guidewire Software, Inc.
Reductions - Charter Communications, Inc.
Complete Exits - None reported
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.